ALTER.PA Stock - Theradiag S.A.
Unlock GoAI Insights for ALTER.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $12.20M | $11.12M | $10.41M | $3.13M | $8.91M |
| Gross Profit | $5.47M | $4.84M | $4.91M | $-835,280 | $4.80M |
| Gross Margin | 44.8% | 43.5% | 47.1% | -26.7% | 53.9% |
| Operating Income | $-274,138 | $-879,047 | $-497,226 | $-4,707,938 | $-501,171 |
| Net Income | $-487,582 | $-766,963 | $-231,052 | $-3,792,017 | $-787,159 |
| Net Margin | -4.0% | -6.9% | -2.2% | -121.1% | -8.8% |
| EPS | $-0.04 | $-0.06 | $-0.02 | $-0.25 | $-0.08 |
Theradiag SA develops, manufactures, and markets in-vitro diagnostic products. It offers autoimmunity reagents; IMMUNO-TROL, a multi-parametric quality control tool; various instruments for autoimmunity and infectious diseases testing; SQA-V system, a semen analyzer; and V-Sperm for loading results, pictures, and videos of the samples into the computer. The company also provides instrumentation, including Theralis that integrates multiplex FIDIS immunofluorescence and ELISA; Theralis µ, a solution for medium sized laboratories; and FIDIS platform used in laboratory for analysis. In addition, it offers therapeutic drug monitoring services for treatment of chronic inflammatory diseases; and LISA tracker, a tool for monitoring of biotherapies, as well as Elisa and rapid tests for SARS-CoV 2 serology. The company was founded in 1986 and is based in Marne La Vallee, France.
Visit WebsiteEarnings History & Surprises
ALTER.PAEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2023 | Oct 11, 2023 | — | — | — | — |
Q2 2023 | Apr 12, 2023 | — | — | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.03 | — | — |
Q4 2022 | Oct 27, 2022 | — | — | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 21, 2022 | — | — | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.05 | — | — |
Q4 2021 | Nov 21, 2021 | — | — | — | — |
Q3 2021 | Jul 20, 2021 | — | $-0.01 | — | — |
Q1 2021 | Mar 22, 2021 | — | — | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q3 2020 | Sep 21, 2020 | — | — | — | — |
Q2 2020 | Jun 26, 2020 | — | $-0.03 | — | — |
Q1 2020 | Mar 18, 2020 | — | — | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.25 | — | — |
Q3 2019 | Sep 24, 2019 | — | — | — | — |
Q1 2019 | Mar 27, 2019 | — | — | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.08 | — | — |
Q3 2018 | Sep 19, 2018 | — | — | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.01 | — | — |
Latest News
Frequently Asked Questions about ALTER.PA
What is ALTER.PA's current stock price?
What is the analyst price target for ALTER.PA?
What sector is Theradiag S.A. in?
What is ALTER.PA's market cap?
Does ALTER.PA pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ALTER.PA for comparison